Millipore Sigma Vibrant Logo

481981 Nifedipine - CAS 21829-25-4 - Calbiochem

Relatively selective blocker of L-type Ca2+ channels.

Nifedipine - CAS 21829-25-4 - Calbiochem: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: L-Type Calcium Channel Blocker III

Primary Target: L-type Ca2+ channels
View Products on Sigmaaldrich.com
481981
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
21829-25-4C₁₇H₁₈N₂O₆

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
481981-250MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 250 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewRelatively selective blocker of L-type Ca2+ channels. One of the most extensively studied blockers of 1,4-dihydropyridine-type Ca2+ channels, and a pharmacologically-useful vasodilator. Induces apoptosis in human glioblastoma cells.
      Catalogue Number481981
      Brand Family Calbiochem®
      SynonymsL-Type Calcium Channel Blocker III
      References
      ReferencesReid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.
      Product Information
      CAS number21829-25-4
      ATP CompetitiveN
      FormYellow solid
      Hill FormulaC₁₇H₁₈N₂O₆
      Chemical formulaC₁₇H₁₈N₂O₆
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetL-type Ca2+ channels
      Purity≥98% by UV
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSUS7975000
      Safety Information
      R PhraseR: 22

      Harmful if swallowed.
      S PhraseS: 36-26

      Wear suitable protective clothing.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      481981-250MG 04055977183443

      Documentation

      Nifedipine - CAS 21829-25-4 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Nifedipine - CAS 21829-25-4 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      481981

      Referencias bibliográficas

      Visión general referencias
      Reid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-May-2008 RFH
      SynonymsL-Type Calcium Channel Blocker III
      DescriptionRelatively selective blocker of L-type Ca2+ channels. One of the most extensively studied Ca2+ channel blockers of 1,4-dihydropyridine-type and a pharmacologically useful vasodilator. Induces apoptosis in human glioblastoma cells.
      FormYellow solid
      CAS number21829-25-4
      RTECSUS7975000
      Chemical formulaC₁₇H₁₈N₂O₆
      Structure formulaStructure formula
      Purity≥98% by UV
      SolubilityDMSO or Ethanol
      Storage Protect from light
      +15°C to +30°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 6528
      ReferencesReid, K., et al. 1997. J. Pharmacol. Exp. Ther. 283, 993.
      Kondo, S., et al. 1995. J. Neurosurg. 82, 469.
      Antkiewicz-Michaluk, L., et al. 1994. Eur. J. Pharmacol. 254, 9.
      Calabresi, P., et al. 1994. J. Neurosci. 14, 4871.
      Akman, M.S., et al. 1993. Endocrinology 132, 1286.
      Cirillo, M., et al. 1993. Circ. Res. 72, 847.
      Young, R.J., et al. 1993. Biochim. Biophys. Acta 1146, 81.
      Janis, R., et al. 1987. Adv. Drug Res. 16, 311.